The Kaluga region showed its best at the international exhibition and forum “Russia”

Last week, on January 12, 2023, the grand opening of the Day of the Kaluga Region took place at the international exhibition and forum “Russia”. The head of the region, Vladislav Shapsha, took part in the festive ceremony and presented the key achievements of the region. The opening was attended by the Director General of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Academician of the Russian Academy of Sciences and Russian Academy of Education Andrey Kaprin, Director of the A. Tsyb MRRC, Corresponding Member of the Russian Academy of Science Sergei Ivanov and the team of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation. The general director of the Voenfilm film studio, People’s Artist of Russia Igor Ugolnikov, Honored Master of Sports of Russia Ilya Averbukh, Honored Artist of the Russian Federation Gediminas Taranda and other guests who successfully implement their projects and programs in the region also came to support the Kaluga residents at the exhibition.

Vladislav Shapsha reminded the guests about the legendary people: scientist, founder of modern cosmonautics Konstantin Tsiolkovsky, Marshal of Victory Georgy Zhukov, Russian polar explorer of the Arctic Vasily Pronchishchev, who are not only the pride of the Kaluga region, but also made a special contribution to the development of national and world history.

Talking about the region’s championship, the governor paid special attention to the construction of the world’s first nuclear power plant in the city of Obninsk. Vladislav Valerievich also recalled that, construction of the first radiopharmaceutical production plant in our country began in the region in 2023. Both the educational and industrial environments are developing most actively in the region.

During the busy business program of the Kaluga Region Day, a round table “Nuclear Medicine Starts Here” was held in the Atom pavilion, moderated by Andrey Kaprin. Opening the session, he noted that nuclear medicine is one of the most rapidly developing areas, largely thanks to the support of the Russian Ministry of Health, the head of the region, where the latest domestic radiopharmaceuticals are being developed and tested today.

In turn, Vladislav Shapsha emphasized that there is the largest production of radioisotopes is localized and starting from 2025 in Kaluga region, thanks to the construction of the largest plant (designed for 21 production lines), Russia’s needs for radiopharmaceuticals will be fully met. “The development of nuclear medicine technologies is impossible without the A. Tsyb MRRC (branch of the Federal State Budgetary Institution of the “National Medical Research Radiological Centre” of the Ministry of Health of the Russian Federation) and the school of Obninsk scientists who have achieved outstanding results in this matter. And today this work continues.”

The general director of Karpov Institute of Physical Chemistry Oleg Kononov, head of the department of radiosurgical treatment with open radionuclides of the A. Tsyb MRRC Valery Krylov, doctor of the department of x-ray surgical methods of diagnosis and treatment of the A. Tsyb MRRC Artur Petrosyan, Head of the Laboratory of Experimental Nuclear Medicine of the A. Tsyb MRRC Victoria Tishchenko, gynecological oncologist, gynecological department with chemotherapy of the N. Lopatkin SRI of Urology and Interventional Radiology Maria Meshkova and Head of the Department of Molecular Genetics and Cell Technologies of National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Doctor of Medical Sciences Lyudmila Lyubchenko.

During the scientific session, participants talked about the achievements of the National Medical Research Radiological Centre and technologies in the diagnosis and treatment of patients using radiopharmaceuticals. Let us recall that at the beginning of 2023, a nuclear pharmacy was opened at the Center, which made it possible to carry out a full cycle of production of medicines before their direct use in the clinic. Here, innovative radiopharmaceuticals based on rhenium, lutetium and actinium radionuclides developed at the Center are synthesized for the treatment of patients with metastatic prostate cancer, primary and secondary liver cancer, metastatic lesions of the skeleton and liver, as well as those suffering from chronic synovitis of the knee joint. In addition, in the future the pharmacy plans to produce drugs for the treatment of neuroendocrine malignancies, non-Hodgkin’s lymphoma and glioblastomas.